State of the Environment

2006

Indicator: CO-09 Number of compounds from coastal and marine sources at some stage of commercial development

Data

There is no mechanism at present for counting the number of marine compounds and medicines that are currently used or being developed for commercial use. However, of the top 150 prescription drugs used in the US, 118 originate from natural sources: 74 per cent from plants, 18 per cent from fungi, five per cent from bacteria, and three per cent from one vertebrate (a snake species) (Daily et al. 1997).

Some recent examples of research into marine compounds turning up promising results can be cited.

For example, a 2002 paper from the Australian Institute of Marine Research describes research which found that treating a tropical marine bacterium to UVA radiation significantly enhanced the antioxidant form of a coenzyme (Q5) . Given the relationship between metabolic oxidation and ageing processes in humans, the researchers conclude that marine bacteria, having evolved to establish an oxygenic environment, may serve as a cellular model to probe regulation of human ageing processes. They consider that marine bacteria may offer a therapeutic strategy to retard the progressive debilitation and the development of degenerative disease in human ageing.

Source: Dunlap et al 2002, Environmental biochemistry and photobiology, viewed 9 May 2006, http://www.aims.gov.au/pages/research/environmental-biochemistry/aapm-01.html.

What the data mean

Data to populate the indicator are not available. The example is merely illustrative of the importance and potential importance of this contribution of marine biodiversity to human life.

Data Limitations

No data available, example only.

Issues for which this is an indicator and why

Coasts and Oceans — Contributions of the coasts and oceans to human life - Medicines and other potentially useful biological compounds 

Marine organisms are a source of potentially useful biological compounds, including medicines. Number of compounds originating from the oceans that are at some stage of commercial development would be indicative of the ocean’s past, current and potential future contribution to medicine and science.

Biodiversity — Utilisation and value of biodiversity - Harvesting and trade in wildlife 

Trends in the development of medicines and other useful compounds from marine biodiversity is an indicator of trends in the harvesting of biodiversity.

Other indicators for this issue:

Human Settlements — Services provided by the environment to human settlements - Medicines and biological compounds 

A proportion of the food fish consumed in human settlements in Australia derives from aquaculture.

Other indicators for this issue:

Further Information

Key

   Links to another web site
   Links to data in the DRS
   Opens a pop-up window

PDF files

Adobe Acrobat Reader  is required to view PDF files.

If you are unable to access a PDF file, please contact us to organise a suitable alternative format.